Sulphonamides: N-(2-hydroxyethyl)-N-methylperfluorooctane sulphonamide

In 2024, sulphonamides: n-(2-hydroxyethyl)-n-methylperfluorooctane sulphonamide trade exhibited significant decline, with global flows reaching $37,908 and a three-year compound annual growth rate of -51.7% (five-year: -49.5%). The all-time peak of $6,167,123 was recorded in 2005; the current level is 99% below that high-water mark.

Over the 30-year observation window (1995–2024), 41% of years recorded positive growth, indicating significant cyclicality with frequent contractions. Trend momentum is decelerating (-19.9% acceleration).

The supply side is moderately concentrated (Herfindahl-Hirschman Index 0.246). The three largest exporters — Barbados ($3.3M), Spain ($1.9M), and Singapore ($1.2M) — collectively dominate supply flows. The leading exporter has grown at -66.3% over the last three years.

On the demand side, importer concentration is moderately concentrated (HHI 0.200). The three largest import markets are Portugal ($190.1K), Brazil ($120.2K), and Israel ($83.1K). The largest importing market sources from 1 different supplying countries.

The dominant trade corridor is Barbados → Japan at $3.2M, representing 100.0% of the importer's total demand.

The volatility score for sulphonamides: n-(2-hydroxyethyl)-n-methylperfluorooctane sulphonamide is 73 out of 100, classified as high. This product exhibits above-average trade variability, making it important to monitor supply chain resilience and price exposure.

For market entrants, contracting demand signals caution before committing resources. A moderately concentrated market rewards differentiated positioning and strategic partner selection.

Data confidence is rated "High" based on reporting coverage and consistency across OECD member and partner countries.